Skip to content
‹ Back to IndustriesSciences

What You Need to Know in B2B This Weekend

Blue Origin, a commercial space flight company, successfully launched and landed the same rocket for the sixth time, reaching a peak altitude of 65 miles. The potential impact of commercial space flight on industries is significant, as highlighted by LinkedIn's annual Emerging Jobs Report. The report identifies roles like AI Specialist, Robotics Engineer, and Data Scientist as increasingly important.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Geoff Short · · AmazonB2bB2b NewsBlue Origin
Share
What You Need to Know in B2B This Weekend

Key takeaways

01

Blue Origin's rocket reached 65 miles above Earth, entering space.

02

Commercial space flight is poised to impact various industries in the next decade.

03

LinkedIn's Emerging Jobs Report points to AI Specialist and Robotics Engineer as rapidly growing roles.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

We talk a lot about Amazon on these updates but today we’re starting with another Jeff Bezos company.

Blue Origin, a commercial space flight company, reached another milestone yesterday when it successfully launched and landed the same rocket for the sixth time.

The spacecraft reached a peak altitude of 65 miles, which is past the official threshold for space.

Commercial space flight could make a major impact in the next decade, but as we turn to a new decade in just a couple weeks, here’s what LinkedIn says will be on the rise in 2020.

The company just released its annual Emerging Jobs Report and listed AI Specialist, Robotics Engineer and Data Scientist as the roles that grew the most in the last year.

And we wrap up today with a major event in the sports racing world. Performance Racing Industry 2019 is underway in Indianapolis and runs through Saturday.

More than 1,000 exhibiting companies will be on the scene and racing teams and part manufacturers will be able to exchange the latest products and ideas at the event.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

GS
Geoff Short
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Verdel's Q-2DMS aims to bring 2D mass spectrometry to more common hardware

Verdel's Q-2DMS aims to bring 2D mass spectrometry to more common hardware

Verdel and Warwick have developed a version of two-dimensional mass spectrometry called Q-2DMS. Until now, only the best-funded centers could afford 2DMS hardware, and Verdel's chief executive argues that the field lacked access, not an understanding of what the method can do. If 2DMS moves onto more common hardware, more labs could evaluate it. Published results show up to tenfold more usable spectral information on closely related or near-isobaric compounds, the look-alike molecules that separation and filtering tend to blur together or drop.

  • 01The reported gain of up to tenfold more usable spectral information applies to closely related or near-isobaric compounds, so the best trial samples are the mixtures chromatography struggles to separate.
  • 02A complete time-stamped record can be revisited after a sample runs out or degrades, and a full acquisition could, in principle, let archived runs address new questions later.

Oct 9, 2026

Antibody developability checks are moving into discovery instead of waiting for development

Antibody developability checks are moving into discovery instead of waiting for development

Maria Gonzalez-Pajuelo of FairJourney Bio says the order in antibody discovery is changing: developability has become a much more important consideration during discovery, rather than an issue left until later-stage development. The goal, she says, is that what comes out of discovery is something CMC can take forward easily.

  • 01Discovery-stage developability screens can rank many antibodies tested once or twice and may reduce surprises later in development, while development still focuses on several lots of a single antibody and answers different questions.

Oct 1, 2026

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

ISPE’s 2026 Annual Meeting and Expo in Washington, DC organizes its program around five tracks running from discovery to governance, with international program committee chair Connie Langer of Pfizer Global Supply and executive chair Jose Caraballo of JCO Global Advisory LLC describing how the tracks connect—and why AI is treated as a cross-cutting topic rather than a standalone track. Deloitte’s December 2025 survey of 280 executives frames the mood the program is built for.

  • 01ISPE’s 2026 Annual Meeting has no dedicated AI track; executive chair Jose Caraballo expects AI presentations across all five tracks, from discovery to governance.
  • 02Deloitte’s December 2025 survey of 280 biopharma and medtech C-suite executives found more than 75% confident in their own outlook but only 41% optimistic about the global economy, a mood the story says the ISPE chairs are programming for.
  • 03A staffing firm reports life sciences job openings falling even as digital fluency becomes a required skill, so the upskilling burden lands on the people already employed, which is where the mandatory, university-partnered AI training Connie Langer describes at her company sits.

Sep 30, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

GS
Geoff Short

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512